Molecular and Cellular Biology, April 2004, p. 3125-3131, Vol. 24, No. 8
0270-7306/04/$08.00+0 DOI: 10.1128/MCB.24.8.3125-3131.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Conditional Inactivation of the Men1 Gene Leads to Pancreatic and Pituitary Tumorigenesis but Does Not Affect Normal Development of These Tissues
Christine A. Biondi,1,
Michael G. Gartside,1 Paul Waring,2,3 Kelly A. Loffler,1 Mitchell S. Stark,1 Mark A. Magnuson,4 Graham F. Kay,1 and Nicholas K. Hayward1*
Queensland Institute of Medical Research, Herston, Queensland,1
Department of Pathology, Peter MacCallum Cancer Institute, East Melbourne,2
Department of Pathology, University of Melbourne, Melbourne, Victoria, Australia,3
Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, Tennessee4
Received 23 October 2003/
Accepted 8 January 2004
Mutations of the MEN1 gene, encoding the tumor suppressor menin, predispose individuals to the cancer syndrome multiple endocrine neoplasia type 1, characterized by the development of tumors of the endocrine pancreas and anterior pituitary and parathyroid glands. We have targeted the murine Men1 gene by using Cre recombinase-loxP technology to develop both total and tissue-specific knockouts of the gene. Conditional homozygous inactivation of the Men1 gene in the pituitary gland and endocrine pancreas bypasses the embryonic lethality associated with a constitutional Men1-/- genotype and leads to ß-cell hyperplasia in less than 4 months and insulinomas and prolactinomas starting at 9 months. The pituitary gland and pancreas develop normally in the conditional absence of menin, but loss of this transcriptional cofactor is sufficient to cause ß-cell hyperplasia in some islets; however, such loss is not sufficient to initiate pituitary gland tumorigenesis, suggesting that additional genetic events are necessary for the latter.
* Corresponding author. Mailing address: Queensland Institute of Medical Research, 300 Herston Rd., Herston, Queensland 4029, Australia. Phone: 61-7-3362 0308. Fax: 61-7-3845 3508. E-mail: nickH{at}qimr.edu.au.
Present address: Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Molecular and Cellular Biology, April 2004, p. 3125-3131, Vol. 24, No. 8
0022-538X/04/$08.00+0 DOI: 10.1128/MCB.24.8.3125-3131.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Hussein, N., Lu, J., Casse, H., Fontaniere, S., Morera, A.-M., Guittot, S. M., Calender, A., Di Clemente, N., Zhang, C. X
(2008). Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-{beta} pathways in Leydig cell lesions developed in male heterozygous multiple endocrine neoplasia type 1 mutant mice. Endocr Relat Cancer
15: 217-227
[Abstract]
[Full Text]
-
La, P., Yang, Y., Karnik, S. K., Silva, A. C., Schnepp, R. W., Kim, S. K., Hua, X.
(2007). Menin-mediated Caspase 8 Expression in Suppressing Multiple Endocrine Neoplasia Type 1. J. Biol. Chem.
282: 31332-31340
[Abstract]
[Full Text]
-
Fontaniere, S, Tost, J, Wierinckx, A, Lachuer, J, Lu, J, Hussein, N, Busato, F, Gut, I, Wang, Z-Q, Zhang, C-X
(2006). Gene expression profiling in insulinomas of Men1 {beta}-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic {beta}-cell tumorigenesis. Endocr Relat Cancer
13: 1223-1236
[Abstract]
[Full Text]
-
Busygina, V., Kottemann, M. C., Scott, K. L., Plon, S. E., Bale, A. E.
(2006). Multiple Endocrine Neoplasia Type 1 Interacts with Forkhead Transcription Factor CHES1 in DNA Damage Response.. Cancer Res.
66: 8397-8403
[Abstract]
[Full Text]
-
Schnepp, R. W., Chen, Y.-X., Wang, H., Cash, T., Silva, A., Diehl, J. A., Brown, E., Hua, X.
(2006). Mutation of Tumor Suppressor Gene Men1 Acutely Enhances Proliferation of Pancreatic Islet Cells. Cancer Res.
66: 5707-5715
[Abstract]
[Full Text]
-
Lee, J.-Y., Ristow, M., Lin, X., White, M. F., Magnuson, M. A., Hennighausen, L.
(2006). RIP-Cre Revisited, Evidence for Impairments of Pancreatic beta-Cell Function. J. Biol. Chem.
281: 2649-2653
[Abstract]
[Full Text]
-
Chen, Y.-X., Yan, J., Keeshan, K., Tubbs, A. T., Wang, H., Silva, A., Brown, E. J., Hess, J. L., Pear, W. S., Hua, X.
(2006). The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression. Proc. Natl. Acad. Sci. USA
103: 1018-1023
[Abstract]
[Full Text]
-
Karnik, S. K., Hughes, C. M., Gu, X., Rozenblatt-Rosen, O., McLean, G. W., Xiong, Y., Meyerson, M., Kim, S. K.
(2005). Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. Proc. Natl. Acad. Sci. USA
102: 14659-14664
[Abstract]
[Full Text]
-
Scacheri, P. C., Kennedy, A. L., Chin, K., Miller, M. T., Hodgson, J. G., Gray, J. W., Marx, S. J., Spiegel, A. M., Collins, F. S.
(2004). Pancreatic Insulinomas in Multiple Endocrine Neoplasia, Type I Knockout Mice Can Develop in the Absence of Chromosome Instability or Microsatellite Instability. Cancer Res.
64: 7039-7044
[Abstract]
[Full Text]
-
Busygina, V., Suphapeetiporn, K., Marek, L. R., Stowers, R. S., Xu, T., Bale, A. E.
(2004). Hypermutability in a Drosophila model for multiple endocrine neoplasia type 1. Hum Mol Genet
13: 2399-2408
[Abstract]
[Full Text]
Copyright © 2004 by the American Society for Microbiology. All rights reserved.